Transcriptional repression by the SMRT-mSin3 corepressor: Multiple interactions, multiple mechanisms, and a potential role for TFIIB

Molecular and Cellular Biology

Volumn 18, Issue 9, 1998, Pages 5500-5510

  Wong, Chi Wai ^a   Privalsky, Martin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE;

ANIMAL CELL; ARTICLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ANIMALIA; EUKARYOTA;

EID: 0031839177     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.9.5500     Document Type: Article

References (61)

1. Alland, L., R. Muhle, H. Hou, J. Potes, L. Chin, N. Schreiber-Agus, and R. A. DePinho. 1997. Role of N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55.
2. Ayer, D. E., L. Kretzner, and R. N. Eisenman. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-222.
3. Bagy, L., H.-Y. Kao, D. Chakravarti, R. J. Lin, C. A. Hassig, D. E. Ayer, S. L. Schreiber, and R. M. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A and histone deacetylase. Cell 89:373-380.
4. Baniahmad, A., A. C. Kohne, and R. Renkawitz. 1992. A transferable silencing domain is present in the thyroid hormone receptor, in the v-Erb A oncogene product, and in the retinoic acid receptor. EMBO J. 11:1015-1023.
5. Baniahmad, A., I. Ha, D. Reinberg, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1993. Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc. Natl. Acad. Sci. USA 90:8832-8836.
6. Baniahmad, A., X. Leng, T. P. Burns, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley, 1995. The τ4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell. Biol. 15:76-86.
7. Casanova, J., E. Helmer, S. Selmi-Ruby, J. S. Qi, M. Au-Flieger, V. Desai-Yajnik, N. Koudinova, F. Yarm, B. M. Raaka, and H. H. Samuels. 1994. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoid acid receptors from an inhibitory cellular factor. Mol. Cell. Biol. 14:5756-5765.
8. Chen, H.-W., and M. L. Privalsky. 1993. The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms. Mol. Cell. Biol. 13:5970-5980.
9. Chen, H.-W., and M. L. Privalsky. 1997. Retinoid X and retinoic acid receptors interact with TFIIB by distinct mechanisms. Mol. Cell. Endocrinol. 129:55-61.
10. Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
11. Chen, J. D., K. Umesono, and R. M. Evans. 1996 SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc. Natl. Acad. Sci. USA 93:7567-7571.
12. Damm, K., C. C. Thompson, and R. M. Evans. 1989 Protein encoded by v-Erb A functions as a thyroid hormone receptor antagonist. Nature 339: 593-597.
13. DeRurbertis, F., D. Kadosh, S. Henchoz, D. Pauli, G. Reuter, K. Struhl, and P. Spierer. 1991. The histone deacetylase RPD3 counteracts genomic silencing in Drosophila and yeast. Nature 384:589-591.
14. Dhordain, P., O. Albagli, R. J. Lin, S. Ansieau, S. Quief, A. Leutz, J. P. Kerckaert, R. M. Evans, and D. Leprince. 1997. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL-6 oncoprotein. Proc. Natl. Acad. Sci. USA 94:10762-10767.
15. Downes, M., L. J. Burke, P. J. Bailey, and G. E. Muscat. 1996. Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors. Nucleic Acids Res. 2: 4379-4386.
16. Felsenfeld, G. 1996. Chromatin unfolds. Cell 86:13-19.
17. Fondell, J. D., A. L. Roy, and R. G. Roeder. 1993. Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression. Genes Dev. 7:1400-1410.
18. Fondell, J. D., F. Brunel, K. Hisatake, and R. G. Roeder. 1996. Unliganded thyroid hormone receptor a can target TATA-binding protein for transcriptional repression. Mol. Cell. Biol. 16:281-287.
19. Grignani, F., S. De Matteis, C. Nervi, L. Tomassoni, V. Gelmetti, M. Cioce, M. Fanelli, M. Ruthardt, F. F. Ferrara, I. Zamir, C. Seiser, F. Grignani, M. A. Lazar, S. Minucci, and P. G. Pelicci. 1998. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukemia. Nature 391:815-818.
20. Guan, K. L., and J. E. Dixon. 1991. Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem. 192:262-267.
21. Hassig, C. A., T. C. Fleischer, A. N. Billin, S. L. Schreiber, and D. E. Ayer. 1997. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89:341-347.
22. Heinzel, T., R. M. Lavinsky, T.-M. Mullen, M. Soderstrom, C. D. Laherty, J. Torchia, W.-M. Yang, G. Brard, S. G. Ngo, J. R. Davie, E. Seto, R. N. Eisenman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1997. A complex containing N-CoR, mSin3, and histone deacetylase mediates transcriptional repression. Nature 387:43-48.
23. Hong, S.-H., G. David, C. W. Wong, A. Dejean, and M. L. Privalsky. 1997. SMRT corepressor interacts with PLZF, and with the PML-RARα and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94:9028-9033.
24. Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamel, M. Soderstrom, C. K. Glass, and M. G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
25. Horwitz, K. B., T. A. Jackson, D. L. Bain, J. K. Richer, G. S. Takimoto, and L. Tung. 1996. Nuclear hormone receptor coactivators and corepressors. Mol. Endocrinol. 10:1167-1177.
26. Jackson, T. A., J. K. Richer, D. L. Bain, G. S. Takimoto, L. Tung, and K. B. Horwitz. 1997. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol. Endocrinol. 11:693-705.
27. Johnston, L. A., S. J. Tapscott, and H. Eisen. 1992. Sodium butyrate inhibits myogenesis by interfering with transcriptional activation functions of MyoD and myogenin. Mol. Cell. Biol. 12:5123-5130.
28. Kadosh, D., and K. Struhl. 1997. Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters. Cell 89:365-371.
29. Kurokawa, R., M. Soderstrom, A. Horlein, S. Halachmi, M. Brown, M. G. Rosenfeld, and C. K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454.
30. Laherty, C. D., W.-M. Yang, J.-M. Sun, J. R. Davie, E. Seto, and R. N. Eisenman. 1997. Histone deacetylases associated with the mSin3A corepressor mediate Mad transcriptional repression. Cell 89:349-356.
31. Li, H., C. Leo, D. J. Schroen, and J. D. Chen. 1997. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT. Mol. Endocrinol. 11:2025-2037.
32. Lin, R. J., L. Nagy, S. Inoue, W. Shao, W. H. Miller, Jr., and R. M. Evans. 1998. Role of the histone deacetylase complex in acute promyelocytic leukemia. Nature 391:811-814.
33. Luo, R. X., A. A. Postigo, and D. C. Dean. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473.
34. McKenzie, E. A., N. A. Kent, S. J. Dowell, F. Moreno, L. E. Bird, and J. Mellor, 1993. The centromere and promoter factor 1, CPF1, of Saccharomyces cerevisiae modulates gene activity through a family of factors, including SPT21. RPD1 (DIN3), RPD3, and CCR4. Mol. Gen. Genet. 240:374-380.
35. McKnight, G. S., L. Hager, and R. D. Palmiter. 1980. Butyrate and related inhibitors of histone deacetylase block the induction of egg white genes by steroid hormones. Cell 22:469-177.
36. 35a. Muscat, G. E. O., L. J. Burke, and M. Downes. 1998. The corepressor N-CoR and its variants RIP13a and RIPΔ1 directly interact with the basal transcription factors TFIIB, TAFII32, and TAFII70. Nucleic Acids Res. 26:2899-2907.
37. Nasmyth, K., D. Stillman, and D. Kipling. 1987. Both positive and negative regulators of HO transcription are required for mother cell-specific mating type switching in yeast. Cell 48:579-589.
38. Pazin, M. J., and J. T. Kadonaga. 1997. What's up and down with histone deacetylation and transcription? Cell 89:325-328.
39. Rundlett, S. E., A. A. Carmen, R. Kobayashi, S. Bavykin, B. M. Turner, and M. Grunstein. 1996. HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. Proc. Natl. Acad. Sci. USA 93:14503-14508.
40. Sande, S., and M. L. Privalsky. 1996. Identification of TRACs (T3 receptor-associating cofactors) a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mot. Endocrinol. 10:813-825.
41. Sap, J., A. Munoz, H. Schmitt, H. Stunnenberg, and B. Vennstrom. 1989. Repression of transcription mediated by a thyroid hormone response element by the v-Erb A oncogene product. Nature 340:242-244.
42. Schreiber-Agus, N., L. Chin, K. Chen, R. Torres, G. Rao, P. Guida, A. I. Skoultichi, and R. A. DePinho. 1995. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional represser SIN3. Cell 80:777-786.
43. Seol, W., M. J. Mahon, Y. K. Lee, and D. D. Moore. 1996. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol. Endocrinol. 10:1646-1655.
44. Shibata, H., Z. Nawaz, S. Y. Tsai, and B. W. O'Malley. 1997. Gene silencing by COUP-TF is mediated by transcriptional corepressors, N-CoR and SMRT. Mol. Endocrinol. 11:714-724.
45. Smith, C. L., Z. Nawaz, and B. W. O'Malley. 1997. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogn, 4-hydroxytamoxifen. Mol. Endocrinol. 11:657-666.
46. Sternberg, P. W., M. J. Stern, I. Clark, and I. Herskowitz. 1987. Activation of the yeast HO gene by release from multiple positive and negative controls. Cell 48:567-577.
47. Stillman, D. J., S. Dorland, and Y. Yu. 1994. Epistasis analysis of suppressor mutations that allow HO expression in the absence of the yeast SWI5 transcriptional activator. Genetics 136:781-788.
48. Sussel, L., D. Vannier, and D. Shore. 1995. Suppressors of defective silencing in yeast: effects on transcriptional repression at the HMR locus, cell growth, and telomere structure. Genetics 141:873-888.
49. Vidal, M., and R. F. Gaber. 1991 RPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae. Mol. Cell. Biol. 11:6317-6327.
50. Wade, P. A., D. Pruss, and A. P. Wolffe. 1997. Histone acetylation: chromatin in action. Trends Biochem. Sci. 22:128-132.
51. Wang, H., and D. J. Stillman. 1993. Transcriptional repression in Saccharomyces cerevisiae by a SIN3-LexA fusion protein. Mol. Cell. Biol. 13:1805-1814.
52. Wolffe, A. P. 1997. Sinful repression. Nature 387:16-17.
53. 51a. Wong, C.-W., and M. L. Privalsky, Submitted for publication.
54. Yang, W.-M., C. Inouye, Y. Zeng, D, Bearss, and E. Seto. 1996. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulatory RPD3. Proc. Natl. Acad. Sci. USA 93: 12845-12850.
55. Yoshida, M., S. Horinouchi, and T. Beppu. 1995. Trichostatin A and trapoxin: novel chemical probes for the role of histone deacetylation in chromatin structure and function. Bioessays 17:423-430.
56. Zamir, I., H. P. Harding, G. B. Atkins, A. Horlein, C. K. Glass, M. Rosenfeld, and M. A. Lazar. 1996. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell. Biol. 16:5458-5465.
57. Zamir, I., J. Dawson, R. M. Lavinsky, C. K. Glass, M. G. Rosenfeld, and M. A. Lazar. 1997. Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. Proc. Natl. Acad. Sci. USA 94:14400-14411.
58. Zamir, I., J. Zhang, and M. A. Lazar. 1997. Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev. 11: 835-846.
59. Zervos, A. S., J. Gyuris, and R. Brent. 1993. Mxi 1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223-232.
60. Zhang, J., I. Zamir, and M. A. Lazar. 1997. Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor-regulated transcriptional repression. Mol. Cell. Biol. 17:6887-6897.
61. Zhang, Y., R. Iratni, H. Erdjument-Bromage, P. Tempst, and D. Reinberg. 1997. Histone deacetylases and SAP18 a novel polypeptide, are components of a human Sin3 complex. Cell 89:357-364.